… Use of a short-acting bronchodilator agent by nebulization is … Improvement in lung function
with a nebulized albuterol-… a corticosteroid to bronchodilator therapy significantly reduces …

… up to 16 puffs each of albuterol or fenoterol administered with an … Continuous nebulization
of beta-adrenergic bronchodilators … of continuous nebulization of bronchodilator aerosols have …

… The effectiveness of nebulized bronchodilator therapy in patients with acute or chronic …
When nebulizing bronchodilators with either 100 % oxygen or air (21 % oxygen and 79 % …

… Short-acting bronchodilators are those most often used in nebulization, with drugs such as
salbutamol and ipratropium bromide being currently available. Their combined use has been …

… We recruited patients referred for assessment for nebulized bronchodilator therapy by
respiratory physicians in our institution, and who remained symptomatic despite treatment with …

… Finally, we discuss the current applications of nebulized therapy in patients … bronchodilator
therapy (LABA/LAMA). Citation60 The availability of these bronchodilators via nebulization …

… -rate were measured before and 10–20 min after the nebulization of the salbutamol. … end
of nebulization. Increasing fill-volume with jet-nebulizer enhanced the bronchodilator effect of …

… effects of nebulized bronchodilator therapy (albuterol and ipratropium) on heart rate and
arrhythmias in this population and tests the proposition that levalbuterol is safer than albuterol in …

… associated with nebulized ipratropium bromide and salbutamol therapy for … Nebulized
bronchodilator therapy is safe in … ipratropium bromide and salbutamol nebulization in patients with …

… Bronchodilator therapy was administered via nebulizer, … (within 15 min of nebulization).
Supplemental oxygen was given … 90 min following the start of nebulization. Once eligibility criteria …